Mobile
Votre recherche
Phase: ongoing
Coombe Women and Infants University Hospital (Ireland) MAJ Il y a 4 ans

A trial to investigate the role of the food supplement inositol in the general health of those at risk of developing gestational diabetes mellitus Background and study aims Gestational diabetes mellitus is a form of diabetes that can occur in pregnancy. This can affect both mother and baby during the course of the pregnancy and delivery. Inositol is a food supplement which has been shown in small studies to have health benefits including reducing the incidence of gestational diabetes in those at risk of getting it. The aim of our study is to find out the possible health benefits of Inositol for women at risk. This includes finding out if they have a decreased incidence of gestational diabetes, if they have fewer complications during delivery, if their baby's weight is affected and if their baby's first few days of life is affected. Who can participate? Women who are 10-14 weeks pregnant and who are at risk of developing gestational diabetes due to a family history of diabetes, can participate in the study. What does the study involve? Participants will be randomly allocated to one of two groups: the intervention group or the placebo (dummy) group. The intervention group will take one tablet every day containing Inositol combined with folic acid and the placebo group will take folic acid alone. They will then follow standard care and be tested as routine for gestational diabetes at 26 weeks. If they have diabetes they will attend the diabetes clinic and if not they will follow standard care. Their pregnancy will be followed until delivery. The type of delivery they have, the weight or their baby and any complications for themselves or their baby will be recorded. What are the possible benefits and risks of participating? The benefit of participating in this study is that it may have health benefits for them. There are no expected risks in participating. Studies have not shown any side effects of Inositol at the doses we are using. Where is the study run from? The study will be run in the Coombe Women and Infant's University Hospital, Ireland. When is the study starting and how long is it expected to run for? The study is expected to run from November 2013 to June 2015. Who is funding the study? The Coombe Women and Infants University Hospital, Ireland. Who is the main contact? Dr Maria Farren [email protected]

  • Pays Aucun
  • Organes Aucun
  • Spécialités Aucun
Essai clos aux inclusions
Plus d'informations
ictrp MAJ Il y a 4 ans

The role of long chain omega-3 polyunsaturated fatty acids on weight loss and maintenance

  • Pays Aucun
  • Organes Aucun
  • Spécialités Aucun
Essai ouvert aux inclusions
Plus d'informations
Rasheed Ahmad, PhD MAJ Il y a 4 ans

Breathing & Mild Physical Exercise Therapy for Asthma Overall goal: To apply the investigators' well defined simple, few-minute breathing/ mild physical exercise program and evaluate its efficacy/benefits for the improvement of clinico-immunological outcome in obese patients with asthma. Rationale & Hypothesis: Different breathing exercise regimens currently recommended are not well defined and in certain cases may worsen dyspnea or even trigger an asthma attack. Therefore, it is important to evaluate the overall usefulness of a breathing exercise as a therapeutic intervention of asthma. In this regard, the investigators have designed an easy, few-minute breathing exercise program as a treatment modality for asthma and to evaluate its efficacy in improving associated clinico-immunological symptoms. The investigators hypothesize that the investigators' well-designed breathing/mild physical exercise intervention for obese patients will help alleviate the stress and symptoms of asthma by reducing the chronic low-grade systemic inflammation and thus potentiate the beneficial outcome of medication to render a better control over the disease and to improve the quality of life in obese patients. Clinical relevance/Significance: The investigators expect that their exercise module will help reduce inflammation caused by asthma, and thereby relieving symptoms of asthma. If successful, this would allow regular individualized exercise module to be recommended as a part of therapy for people with asthma, which could possibly reduce the dosage as well as frequency of taking medicine that they need.

  • Pays Aucun
  • Organes Aucun
  • Spécialités Aucun
Essai ouvert aux inclusions
Plus d'informations
ictrp MAJ Il y a 4 ans

The superior anesthetic management scheme during perioperative period for myasthenia gravis patients

  • Pays Aucun
  • Organes Aucun
  • Spécialités Aucun
Essai ouvert aux inclusions
Plus d'informations
ictrp MAJ Il y a 4 ans

Validation of the Microlife BP A200 IMT and BP3GK1-4E automated blood pressure monitors

  • Pays China,
  • Organes Aucun
  • Spécialités Aucun
Essai ouvert aux inclusions
Plus d'informations